Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Aggrenox vs Dipyridamole IR + Aspirin under reduced stomach acidity
NCT02251184Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2000
- Primary completion
- Nov 2000
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of dipyridamole in stroke, Transient Ischemic Attack (TIA), sponsored by Boehringer Ingelheim. Started Oct 2000; status: completed.
02
Drugs
dipyridamole
03
Conditions
strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT02251184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02251184.